Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

Inclusion Criteria

• •Male and female Europeans at the age of 18 years or above with hypertension, metabolic syndrome, and modest inflammation
• •Blood pressure greater than or equal to 130/85 mmHg AND
• •hs-CRP greater than or equal to 1.0 and less than 10.0 mg/dL AND at least two (2) of the following traits of the metabolic syndrome (ATP III criteria):
• •abdominal obesity: waist circumference greater than 102 cm for men and 88 cm for women;
• •triglyceride level greater than or equal to 150 mg/dL; HDL less than 40 mg/dL for men and less than 50 mg/dL for women
• •fasting blood glucose greater than or equal to 110mg/dL